Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Adrien Monard

4PUBLICATIONS

6CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 04, 2025

Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE study.

Jerome Alexandre, Philippe Boudier, Elise Lavit

|Jul 13, 2023

Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab.

Emmanuelle Jacquet, Fiona Pham, Billy Taouk

|May 23, 2022

Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.

Fiona Y-V Pham, Emmanuelle Jacquet, Amina Taleb

|Mar 25, 2021

Access to innovation through the national early access program and clinical trials for patients with malignant melanoma.

Claire Christen, Laetitia Belgodère, Bernard Guillot

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas Albin

1 joint publications

Claire Christen

1 joint publications

Jean-Yves Blay

1 joint publications

Jerome Alexandre

1 joint publications

Frederic Selle

1 joint publications

Mathilde Cancel

Frequent Collaborators

2 joint publications

Nicolas Albin

1 joint publications

Claire Christen

1 joint publications

Jean-Yves Blay

1 joint publications

Jerome Alexandre

Top Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

See more related videos

Top Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

See more related videos